ArticleFrontiers in medicine2022

SARS-CoV-2 antibody response after BBIBP-CorV (Sinopharm) vaccination in cancer patients: A case-control study.

Fahimeh Safarnezhad Tameshkel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.